| Symbol | Name | Grade | Market Cap | Country |
|---|---|---|---|---|
| 603259.CN | WuXi AppTec Co., Ltd. Class A | 86.5 | ¤69,762 | CN |
| 002001.CN | Zhejiang NHU Co. Ltd. Class A | 75.3 | ¤12,014 | CN |
| 002653.CN | Haisco Pharmaceutical Group Co. Ltd. Cla | 69.3 | ¤10,715 | CN |
| 688578.CN | Shanghai Allist Pharmaceuticals Co. Ltd. | 90.5 | ¤6,675 | CN |
| 688336.CN | Sunshine Guojian Pharmaceutical (Shangha | 91.1 | ¤5,322 | CN |
| Symbol | Name | Grade | Market Cap | Country |
|---|---|---|---|---|
| 300515.CN | Hunan Sundy Science and Technology Co., | 79.8 | ¤456 | CN |
| 002107.CN | Shandong Wohua Pharmaceutical Co., Ltd. | 54.1 | ¤576 | CN |
| 688580.CN | Nanjing Vishee Medical Technology Co., L | 57.3 | ¤601 | CN |
| 688410.CN | SWS Hemodialysis Care Co., Ltd. Class A | 62.5 | ¤625 | CN |
| 300871.CN | Hvsen Biotechnology Co. Ltd. Class A | 60.0 | ¤646 | CN |
| Symbol | Name | Grade | Times* | Country |
|---|---|---|---|---|
| 002001.CN | Zhejiang NHU Co. Ltd. Class A | 75.3 | 21 | CN |
| 000423.CN | Dong-E-E-Jiao Co., Ltd. Class A | 65.0 | 20 | CN |
| 600285.CN | Henan Lingrui Pharmaceutial Co., Ltd. Cl | 60.3 | 10 | CN |
| 600867.CN | Tonghua Dongbao Pharmaceutical Co., Ltd. | 69.5 | 10 | CN |
| 002107.CN | Shandong Wohua Pharmaceutical Co., Ltd. | 54.1 | 8 | CN |
| 300453.CN | Jiang Xi Sanxin Medtec Co Ltd Class A | 64.5 | 8 | CN |
| 002603.CN | Shijiazhuang Yiling Pharmaceutical Co., | 56.3 | 6 | CN |
| 688578.CN | Shanghai Allist Pharmaceuticals Co. Ltd. | 90.5 | 6 | CN |
| 002437.CN | Harbin Gloria Pharmaceuticals Co., Ltd. | 59.8 | 5 | CN |
| 300206.CN | Edan Instruments, Inc. Class A | 66.4 | 5 | CN |
| Average Market Cap | ¤4,870 |
| Median Market Cap | ¤1,601 |
| Avg. 3 Mo. Dollar Vol. | ¤95,722,467 |
| Avg. 3 Mo. Trading Vol. | 23,124,831 |
| Last Rebalance Date | 06/15/2026 |
| Companies Replaced | 16 |
| Biggest Sector Increase | Health Care |
| Biggest Sector Decrease | Health Care |
| Trailing P/E Ratio (12 Mo.) | 21.2 |
| Forward P/E Ratio (12 Mo.) | 18.8 |
| Price/Book Ratio | 3.3 |
| Avg. Revenue Chg. - 3 Yr | 46.6% |
| Avg. Op. Income Chg. - 3 Yr. | 52.5% |
| Avg. EPS Growth - 3 Yr. | 19.2% |
| Avg. EPS Growth - 1 Yr. | 10.3% |
| Avg. Operating Margin | 20.5% |
| Avg. LT Debt to Total Capital | 7.1% |
| Avg. Return on Equity | 16.6% |
| Dividend Yield | 1.6% |
| China Health Care Index | 63.31 |
| China | 100.0% |
